| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Hemorrhage | D006470 | 15 associated lipids |
| Hepatic Encephalopathy | D006501 | 9 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Hepatorenal Syndrome | D006530 | 1 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Hypertension, Portal | D006975 | 12 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Infant, Newborn, Diseases | D007232 | 9 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
octanoic acid
octanoic acid is a lipid of Fatty Acyls (FA) class. Octanoic acid is associated with abnormalities such as Ischemia, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes, Cardiomyopathies and Obesity. The involved functions are known as Anabolism, 5-(carboxyamino)imidazole ribonucleotide mutase activity, Citric Acid Cycle, Metabolic Inhibition and Excretory function. Octanoic acid often locates in Pore, Protoplasm, Endothelium, Mitochondria and Muscle. The associated genes with octanoic acid are P4HTM gene, CPT1A gene, HADH gene, ACSL1 Gene and CD36 gene. The related lipids are Fatty Acids, Nonesterified Fatty Acids, Oleates, Palmitates and hexanoic acid.
Cross Reference
Introduction
To understand associated biological information of octanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with octanoic acid?
octanoic acid is suspected in Obesity, Atherosclerosis, Gigantism, Alzheimer's Disease, Neurodegenerative Disorders, Cardiomyopathies and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with octanoic acid
PubChem Associated disorders and diseases
What pathways are associated with octanoic acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with octanoic acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with octanoic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with octanoic acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with octanoic acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with octanoic acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with octanoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Miura T et al. | Purification and properties of ghrelin from the intestine of the goldfish, Carassius auratus. | 2009 | Peptides | pmid:19150635 |
| Kojima M and Kangawa K | The discovery of ghrelin: with a little luck and great passion. Preface. | 2011 | Peptides | pmid:22027335 |
| Wang J et al. | Pharmacokinetics, toxicity of nasal cilia and immunomodulating effects in Sprague-Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers. | 2006 | Peptides | pmid:16242213 |
| Sulkers EJ et al. | Quantitation of oxidation of medium-chain triglycerides in preterm infants. | 1989 | Pediatr. Res. | pmid:2797943 |
| Jones PM et al. | Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency. | 2003 | Pediatr. Res. | pmid:12621125 |
| Trauner DA and Adams H | Intracranial pressure elevations during octanoate infusion in rabbits: an experimental model of Reye's syndrome. | 1981 | Pediatr. Res. | pmid:7267183 |
| Nakajima T et al. | The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency. | 1997 | Pediatr. Res. | pmid:9212045 |
| Whyte RK et al. | Excretion of dicarboxylic and omega-1 hydroxy fatty acids by low birth weight infants fed with medium-chain triglycerides. | 1986 | Pediatr. Res. | pmid:3080726 |
| Trauner DA | Regional cerebral Na+K+ ATPase activity following octanoate administration. | 1980 | Pediatr. Res. | pmid:6250122 |
| Yoshida Y et al. | Effect of salicylic acid on mitochondrial-peroxisomal fatty acid catabolism. | 1988 | Pediatr. Res. | pmid:3353181 |
| Roe CR et al. | Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency. | 1985 | Pediatr. Res. | pmid:4000772 |
| Dombrowski GJ and Swiatek KR | Lactate genesis by rat liver and muscle during development. | 1991 | Pediatr. Res. | pmid:1956716 |
| Trauner DA and Garrett RS | Effect of octanoate injection on rat blood-brain barrier. | 1985 Jan-Feb | Pediatr. Neurol. | pmid:3880386 |
| Trauner DA and de la Torre JC | Effect of octanoate on blood-brain barrier permeability using L-dopa as a marker. | 1985 Jul-Aug | Pediatr. Neurol. | pmid:3880408 |
| Trice JE and Trauner DA | Alterations in serum glucose and hepatic glycogen concentrations during octanoate administration in rabbits. | 1985 Sep-Oct | Pediatr. Neurol. | pmid:3880415 |
| Trauner DA and Adams HR | Effects of therapeutic agents in a rabbit model of Reye syndrome. | 1987 May-Jun | Pediatr. Neurol. | pmid:3508061 |
| Massaldi H and Morais V | Evolution of endotoxin contamination during production of a therapeutic serum. | 2007 Sep-Oct | PDA J Pharm Sci Technol | pmid:18047176 |
| Tezikov EB et al. | [Effect of beta-hydroxybutyrate and caprylic acid on function of isolated rat heart in alcoholic intoxication and in the post-intoxication period]. | 1993 May-Jun | Patol Fiziol Eksp Ter | pmid:8058394 |
| Müller T | Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference. | 2009 | Patient Prefer Adherence | pmid:19936145 |
| Webb T | Identification of interference affecting the gas-liquid chromatography analysis of valproic acid in quality control material. | 1986 | Pathology | pmid:3097616 |